Seoul’s exosome hair-loss menus can look tempting next to U.S. prices—but “regenerative” is not the same as proven.
Here’s what the photos, package deals, and minimal-downtime promises can’t tell a U.S. patient before they book a flight.
First, the FDA reality check: exosomes are not approved hair medicine
Here’s the nonnegotiable starting point: the FDA has approved no exosome product for any condition, including hair loss. A product marketed to treat disease needs FDA drug or biologic review.
A Seoul appointment sits outside FDA oversight, however polished the clinic’s English website looks. FDA does not regulate care performed abroad or verify a clinic’s product, handling, or claims.
⚠️ An FDA-authorized U.S. study is different from a commercial treatment: it has an IND, IRB oversight, and informed consent.
The evidence is still early: a 2025 review found 298 patients across 11 clinical studies, with only two randomized trials. Products varied and follow-up was short, so ask a dermatologist about established options before booking.
Why a dramatic before-and-after is not a graft count
Photos cannot isolate exosomes from minoxidil, finasteride, PRP, lighting, longer hair, styling fibers, or a normal shedding cycle; patient reports often bundle treatments.
| Item | Exosome photo | FUE record (Pick) |
|---|---|---|
| Price | Varies | Quoted by graft |
| Time | Unclear | Operative time |
| Pain | Reported | Documented |
| Downtime | Variable | 1–2 weeks scabs |
| Longevity | Unclear | Months to growth |
| Risk | Product-specific | Procedure-specific |
FUE reporting can name the graft count, extraction method, surgeon, operative time, and follow-up milestones. That makes the procedure auditable, not automatically better.
One RealSelf review reported 1,621 FUE grafts with Dr. Oh Sung Kwon at Forhair Clinic; another cited roughly 3,000 at NEWHAIR. Neither testimonial proves quality or final density.
A count is measurable, not a guarantee: expect scabbing for 1–2 weeks and visible growth over months. Ask for the operative record, then judge results at follow-up—not in a reveal photo.
The real Seoul price is the package—not the first session
BTNanda posts ₩195,000 (about $140) for scalp exosome Derma Shine plus light therapy, or ₩235,000 (about $170) with extra bottles. Those are clinic prices, not a Seoul market standard.
Forena recommends 3–5 sessions every 2–4 weeks, then possible maintenance every 1–2 months—so the package, not the teaser rate, is the real budget.
For context only, Dr. Jennifer Levine’s RealSelf feature listed $1,000 per microneedling-plus-Benev session; individual U.S. reports run from $499 microporation to $4,000 for a procedure.
“Exosome” can mean topical application after microneedling, stamping, manual injection, light therapy, or a clinic formula. Ask for the route, product, vial count, and inclusions before comparing any quote.
Travel-safe questions to ask before you pay a deposit
Before a deposit, ask for your hair-loss diagnosis—not just a “regrowth” promise—and get the product’s exact name, manufacturer, source, lot number, and sterility/storage records in writing.
Also ask who handles infection, inflammation, severe pain, or a delayed reaction once you are home—and whether your records can be released to your U.S. dermatologist. BTNanda lists roughly one recovery day; Forena says redness or tingling can last several days, with no washing that day and no heat treatments for a week.
Set expectations around maintenance, not permanent regrowth: reviews find modest, uneven density changes, while long-term safety and durability remain insufficiently studied. Bring these questions to a board-certified dermatologist before you book.
No—FDA has approved zero exosome products. In the U.S., ask for an IND and IRB consent.
Budget about $1,110–$5,500 for 3–5 Seoul sessions at $370–$1,100 each; maintenance adds cost.
No. Photos cannot isolate exosomes when patients also use minoxidil, finasteride, PRP, or time.
Before flying, get product and lot records, sterility details, credentials, consent, and a complication plan.
